QT-219C / Zhejiang University, The Second Hospital of Anhui Medical University - LARVOL DELTA

CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease (clinicaltrials.gov) - P1 | N=15 | Recruiting | Sponsor: The Children's Hospital of Zhejiang University School of Medicine

New P1 trial • Glomerulonephritis • IgA Nephropathy • Immunology • Inflammatory Arthritis • Lupus • Nephrology • Renal Disease • Scleroderma • Systemic Lupus Erythematosus • Systemic Sclerosis • Vasculitis

UCAR T-cell Therapy Targeting CD19/BCMA in Relapsed/Refractory Autoimmune Hemolytic Anemia (clinicaltrials.gov) - P1 | N=15 | Recruiting | Sponsor: The Second Hospital of Anhui Medical University

New P1 trial • Anemia • Autoimmune Hemolytic Anemia • Hematological Disorders • Immunology